Aristotle Capital Boston Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Acadia Healthcare
ACHC
|
+$6.25M |
| 2 |
QTS
QTS REALTY TRUST, INC.
QTS
|
+$5.98M |
| 3 |
ALE
Allete
ALE
|
+$5.91M |
| 4 |
National Bank Holdings
NBHC
|
+$5.53M |
| 5 |
Carter's
CRI
|
+$5.18M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PRXL
Parexel International Corp
PRXL
|
+$17M |
| 2 |
DGI
DigitalGlobe Inc.
DGI
|
+$11.5M |
| 3 |
Rogers Corp
ROG
|
+$7.06M |
| 4 |
Novanta
NOVT
|
+$5.18M |
| 5 |
OA
Orbital ATK, Inc.
OA
|
+$2.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.87% |
| 2 | Financials | 15.66% |
| 3 | Technology | 14.59% |
| 4 | Healthcare | 11.81% |
| 5 | Consumer Discretionary | 8.65% |
Similar funds
Aristotle Capital Boston's Q4 2017 Portfolio in Review
As of Q4 2017, Aristotle Capital Boston held 125 positions worth $1.37B, up 23% from $1.12B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Aristotle Capital Boston deployed $243M of net new capital in Q4 2017, opening 1 new position and adding to 114 existing holdings. Its largest new stake was HMS Holdings Corp.: 291,021 shares worth $4.93M.
By sector, the portfolio is most concentrated in Industrials at 21% of assets, down from 22% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Rogers Corp, an estimated $7.06M trimmed.
- Aristotle Capital Boston's largest Q4 2017 buy was HMS Holdings Corp.: 291,021 shares worth $4.93M.
- Aristotle Capital Boston added most to Acadia Healthcare in Q4 2017, an estimated $6.25M increase.
- Aristotle Capital Boston's biggest Q4 2017 reduction was Rogers Corp, cutting an estimated $7.06M.
- Aristotle Capital Boston fully exited Parexel International Corp in Q4 2017, selling an estimated $17M.
- Aristotle Capital Boston's ten largest holdings make up 18% of its $1.37B portfolio in Q4 2017.
- Aristotle Capital Boston opened 1 new position and closed 2 in Q4 2017.
- Aristotle Capital Boston's portfolio value rose 23% quarter-over-quarter to $1.37B.
Based on Aristotle Capital Boston's 13F filing for Q4 2017, filed 14 Feb 2018.